California’s Illumina Accelerator — the world’s first business accelerator focused solely on creating an innovation ecosystem for the genomics industry — selects PathoGn Inc. for its spring funding cycle. PathoGn is an infectious disease platform company based in California using genomics and machine learning to build pathogen diagnostics and disease forecasting products for agricultural applications.
PathoGn will receive seed investment, a subscription to Illumina’s NextBio translational genomics database, access to match funding through the $40 million Illumina Accelerator Boost Capital, and Illumina’s sequencing systems and reagents.
In addition, startups accepted into Illumina Accelerator gain access to business guidance and fully operational lab space in the San Francisco Bay Area during the six-month funding cycle.
